BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 10024074)

  • 41. Dynamics of hepatic and peripheral insulin effects suggest common rate-limiting step in vivo.
    Bradley DC; Poulin RA; Bergman RN
    Diabetes; 1993 Feb; 42(2):296-306. PubMed ID: 8093879
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Glucagon suppression improves glucoregulation in moderate but not chronic severe diabetes.
    Lickley HL; Kemmer FW; Doi K; Vranic M
    Am J Physiol; 1983 Oct; 245(4):E424-9. PubMed ID: 6137957
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The direct effects of catecholamines on hepatic glucose production occur via alpha(1)- and beta(2)-receptors in the dog.
    Chu CA; Sindelar DK; Igawa K; Sherck S; Neal DW; Emshwiller M; Cherrington AD
    Am J Physiol Endocrinol Metab; 2000 Aug; 279(2):E463-73. PubMed ID: 10913048
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Insulin is required for the liver to respond to intraportal glucose delivery in the conscious dog.
    Pagliassotti MJ; Moore MC; Neal DW; Cherrington AD
    Diabetes; 1992 Oct; 41(10):1247-56. PubMed ID: 1397697
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fatty acids mediate the acute extrahepatic effects of insulin on hepatic glucose production in humans.
    Lewis GF; Vranic M; Harley P; Giacca A
    Diabetes; 1997 Jul; 46(7):1111-9. PubMed ID: 9200644
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of a selective rise in hepatic artery insulin on hepatic glucose production in the conscious dog.
    Sindelar DK; Igawa K; Chu CA; Balcom JH; Neal DW; Cherrington AD
    Am J Physiol; 1999 Apr; 276(4):E806-13. PubMed ID: 10198319
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nonesterified fatty acids and hepatic glucose metabolism in the conscious dog.
    Moore MC; Satake S; Lautz M; Soleimanpour SA; Neal DW; Smith M; Cherrington AD
    Diabetes; 2004 Jan; 53(1):32-40. PubMed ID: 14693695
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Paradoxical effect of troglitazone in normal animals: enhancement of adipocyte but reduction of liver insulin sensitivity.
    Dea MK; Van Citters GW; Ader M; Mittelman SD; Sunehag AL; Bergman RN
    Diabetes; 2000 Dec; 49(12):2087-93. PubMed ID: 11118011
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Regulation of glucose turnover during exercise in pancreatectomized, totally insulin-deficient dogs. Effects of beta-adrenergic blockade.
    Bjorkman O; Miles P; Wasserman D; Lickley L; Vranic M
    J Clin Invest; 1988 Jun; 81(6):1759-67. PubMed ID: 3290252
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Alpha- and beta-cell responses to small changes in plasma glucose in the conscious dog.
    Flattem N; Igawa K; Shiota M; Emshwiller MG; Neal DW; Cherrington AD
    Diabetes; 2001 Feb; 50(2):367-75. PubMed ID: 11272149
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Glucoregulation during rest and exercise in depancreatized dogs: role of the acute presence of insulin.
    Wasserman DH; Bupp JL; Johnson JL; Bracy D; Lacy DB
    Am J Physiol; 1992 May; 262(5 Pt 1):E574-82. PubMed ID: 1590369
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inclusion of low amounts of fructose with an intraduodenal glucose load markedly reduces postprandial hyperglycemia and hyperinsulinemia in the conscious dog.
    Shiota M; Moore MC; Galassetti P; Monohan M; Neal DW; Shulman GI; Cherrington AD
    Diabetes; 2002 Feb; 51(2):469-78. PubMed ID: 11812757
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of portal and peripheral venous insulin infusion on glucose production and utilization in depancreatized, conscious dogs.
    Ishida T; Chap Z; Chou J; Lewis RM; Hartley CJ; Entman ML; Field JB
    Diabetes; 1984 Oct; 33(10):984-90. PubMed ID: 6383906
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of intraportal glucagon-like peptide-1 on glucose metabolism in conscious dogs.
    Nishizawa M; Moore MC; Shiota M; Gustavson SM; Snead WL; Neal DW; Cherrington AD
    Am J Physiol Endocrinol Metab; 2003 May; 284(5):E1027-36. PubMed ID: 12569088
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Regulation of gluconeogenesis during rest and exercise in the depancreatized dog.
    Wasserman DH; Johnson JL; Bupp JL; Lacy DB; Bracy DP
    Am J Physiol; 1993 Jul; 265(1 Pt 1):E51-60. PubMed ID: 8338154
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relationship between decrements in glucose level and metabolic response to hypoglycemia in absence of counterregulatory hormones in the conscious dog.
    Connolly CC; Adkins-Marshall BA; Neal DW; Pugh W; Jaspan JB; Cherrington AD
    Diabetes; 1992 Oct; 41(10):1308-19. PubMed ID: 1397705
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Importance of substrate changes in the decrease of hepatic glucose cycling during insulin infusion and declining glycemia in the depancreatized dog.
    Shi ZQ; Giacca A; Fisher S; Vidal H; van de Werve G; Vranic M
    Diabetes; 1994 Nov; 43(11):1284-90. PubMed ID: 7926301
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hyperinsulinemia compensates for infection-induced impairment in net hepatic glucose uptake during TPN.
    Donmoyer CM; Chen SS; Hande SA; Lacy DB; Ejiofor J; McGuinness OP
    Am J Physiol Endocrinol Metab; 2000 Aug; 279(2):E235-43. PubMed ID: 10913021
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of somatostatin on nonesterified fatty acid levels modifies glucose homeostasis during fasting.
    Hendrick GK; Frizzell RT; Cherrington AD
    Am J Physiol; 1987 Oct; 253(4 Pt 1):E443-52. PubMed ID: 2889364
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Selective suppression of hepatic glucose output by human proinsulin in the dog.
    Lavelle-Jones M; Scott MH; Kolterman O; Rubenstein AH; Olefsky JM; Moossa AR
    Am J Physiol; 1987 Feb; 252(2 Pt 1):E230-6. PubMed ID: 2881485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.